| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 668336 | Null | 0.00479683626511385 | 0.37765707 |
| NSC 683256 | Null | 0.00479683626511385 | 0.69370258 |
| NSC 702015 | 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- | 0.00479683626511385 | 0.45030946 |
| NSC 709969 | Null | 0.00479683626511385 | 0.69146472 |
| NSC 728037 | 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline | 0.00479683626511385 | 0.42143729 |
| NSC 123461 | Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) | 0.00479683626511392 | 0.2721662 |
| NSC 175633 | 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- | 0.00479683626511392 | 0.41629661 |
| NSC 176503 | Fastigilin B | 0.00479683626511392 | 0.69640146 |
| NSC 32937 | Benzenamine, 4-(9-chloro-10-ethyl-9,10-dihydro-9-acridinyl)-N,N-dimethyl-, dihydrochloride | 0.00479683626511392 | 0.36669577 |
| NSC 329691 | HM-4 | 0.00479683626511392 | 0.60736907 |